molecular marker for minimally invasive diagnostics of either cerebral tumours or inflammable diseases
The work group of Prof. Dr. Eckart Meese at Saarland University identified special features of tumour cells that could constitute a basis for an improved special diagnostic investigation. Tumour antigens were identified which trigger an immune reaction exclusively in patients with glioms or meningeoms. Based on this success re-search was extended on the fields of MS and COPD.
Compared with common procedures, the minimally invasive diagnosis, based on blood analysis, is a very cost-efficient method. Furthermore, this procedure means less inconveniences for the patient (complete blood count only).
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340
Contact
Dipl. Chem. Dagmar Vössing, Dipl.-Kfm. Axel Koch MBA, Dipl. Ing. Gerd Schneider
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Webb captures top of iconic horsehead nebula in unprecedented detail
NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
Novel genetic plant regeneration approach
…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation. For ages now, plants have been the…
